ArticleJournal of gastroenterology2026
Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance study.
Kazuyuki Mizuno et al.PubMed ↗Publisher ↗
No numbers read from the abstract.